SCHEMBL4641004

SCHEMBL4641004

CCCC(CC)OC(=O)c1ccc(CC)cc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.51
PRKCD Q05655 2/20 0.51
ALDH1A1 P00352 3/20 0.42
METAP2 P50579 2/20 0.39
PPARA Q07869 2/20 0.37
PPARG P37231 1/20 0.37
KAT8 Q9H7Z6 2/20 0.37
RARB P10826 2/20 0.36
RARA P10276 1/20 0.36
RARG P13631 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CFD P00746 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4641003 0.93 PRKCA (0.55) PRKCAPRKCDALDH1A1PPARGTSHR
SCHEMBL4641155 0.89 ALDH1A1 (0.40) PRKCAPRKCDALDH1A1METAP2RAB9A
SCHEMBL4640913 0.86 PRKCA (0.48) PRKCAPRKCDALDH1A1TSHRMAPK1
SCHEMBL18628681 0.85 PRKCA (0.55) PRKCAPRKCDALDH1A1PPARAPPARG
SCHEMBL4640705 0.85 PRKCA (0.47) PRKCAPRKCDALDH1A1PPARAPPARG
SCHEMBL4639977 0.85 PRKCA (0.47) PRKCAPRKCDALDH1A1SMN1; SMN2
SCHEMBL4640962 0.85 PRKCA (0.47) PRKCAPRKCDALDH1A1RARBRARA
SCHEMBL4640712 0.85 PRKCA (0.47) PRKCAPRKCDALDH1A1RAB9ASMN1; SMN2
SCHEMBL4640593 0.84 PRKCA (0.51) PRKCAPRKCDALDH1A1PPARAPPARG
SCHEMBL4640740 0.83 PRKCA (0.45) PRKCAPRKCDALDH1A1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX PRKCA 1200/4885PRKCD 552/4885ALDH1A1 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.